Related Experiment Video
Updated: Jun 16, 2026

06:19
Mimicking Ding's Roll Method on Notexin-Induced Muscle Injury in Rats
Published on: August 25, 2023
Adverse events and manual therapy: a systematic review
Dawn Carnes1, Thomas S Mars, Brenda Mullinger
1Barts and The London School of Medicine and Dentistry, Centre for Health Sciences, 2 Newark St, London E1 2AT, UK. d.carnes@qmul.ac.uk
Manual Therapy
|January 26, 2010
Summary
Manual therapies can cause minor to moderate adverse events in about half of patients, though major adverse events are rare. The risk of adverse events is lower compared to drug therapies.
Area of Science:
- Integrative Medicine
- Evidence-Based Practice
- Clinical Research
Background:
- Manual therapies are widely used, necessitating a clear understanding of their safety profiles.
- Assessing adverse events is crucial for patient safety and informed clinical decision-making.
Purpose of the Study:
- To determine the incidence and risk of adverse events associated with manual therapies.
- To compare the risk of adverse events from manual therapies with other common treatments.
Main Methods:
- A systematic literature search was conducted across major health and specialized allied medicine databases.
- Inclusion criteria focused on manual therapies by regulated practitioners with clearly described interventions and reported adverse events.
- Meta-analysis of incident estimates and random effects models were employed to synthesize data from cohort studies and randomized controlled trials (RCTs).
Main Results:
- Data from 8 prospective cohort studies and 31 manual therapy RCTs were analyzed.
- Minor to moderate transient adverse events occurred in approximately 41% (cohort studies) and 22% (RCTs) of patients.
- The incidence of major adverse events was approximately 0.13%.
Conclusions:
- Major adverse events from manual therapy are infrequent, but minor to moderate events are common, affecting roughly half of patients.
- Manual therapies present a lower relative risk of adverse events compared to drug therapies but a higher risk than usual care.